The Influence of Levodopa and the COMT Inhibitor on Serum Vitamin B12 and Folate Levels in Parkinson’s Disease Patients

Serum folate and vitamin B12 levels were measured in 67 consecutive Parkinson’s disease patients treated either with levodopa + dopa decarboxylase inhibitor (DDC-i) plus catechol-O-methyltransferase inhibitors (COMT-i) or only with levodopa + DDC-i. The data were compared to 67 age-matched controls....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European neurology 2007-01, Vol.58 (2), p.96-99
Hauptverfasser:	Triantafyllou, N.I., Kararizou, E., Angelopoulos, E., Tsounis, S., Boufidou, F., Evangelopoulos, M.E., Nikolaou, C., Vassilopoulos, D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Analysis of Variance Antiparkinson Agents - pharmacology Antiparkinson Agents - therapeutic use Case-Control Studies Catechols - pharmacology Catechols - therapeutic use Female Folic Acid - blood Humans Immunoassay - methods Levodopa - pharmacology Levodopa - therapeutic use Male Middle Aged Nitriles - pharmacology Nitriles - therapeutic use Original Paper Parkinson Disease - blood Parkinson Disease - drug therapy Vitamin B 12 - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!